Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease

AK Reinhold, HL Rittner - Experimental neurology, 2020 - Elsevier
A variety of barriers ensures the protection of the peripheral nervous system from noxious
blood-borne or surrounding stimuli. In this review, anatomy and functioning of the blood …

Psychiatric comorbidities in adults with sickle cell disease: A narrative review

AD Mishkin, EJ Prince, EJ Leimbach… - British journal of …, 2023 - Wiley Online Library
Although descriptions of quality of life and patient reports of mood in sickle cell disease
(SCD) have become more common in the literature, less is known about psychiatric illness …

Opioid treatment for acute and chronic pain in patients with sickle cell disease

CP Carroll - Neuroscience Letters, 2020 - Elsevier
Sickle cell disease is a uniquely complex painful disease, with lifelong episodes of
unpredictable acute pain and superimposed chronic pain in adulthood. Both painful crises …

Mouse models of sickle cell disease: imperfect and yet very informative

S Kamimura, M Smith, S Vogel, LEF Almeida… - Blood Cells, Molecules …, 2024 - Elsevier
The root cause of sickle cell disease (SCD) has been known for nearly a century, however,
few therapies to treat the disease are available. Over several decades of work, with …

Chronic pain: prevalence and management

CP Carroll, AM Brandow - Hematology/Oncology Clinics, 2022 - hemonc.theclinics.com
Pain has been recognized as the clinical hallmark of sickle cell disease (SCD) since its
initial description in the Western medical literature more than 100 years ago. Clinical and …

Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events

MB Nawaiseh, AM Yassin, MQ Al-Sabbagh… - Neurology: Clinical …, 2024 - AAN Enterprises
Background and Objectives Patients with sickle cell disease (SCD) are prone to
symptomatic neurologic complications. Previous studies reported accrual of neural injury …

[HTML][HTML] Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity

TB Waltz, D Chao, EK Prodoehl, JD Enders, VL Ehlers… - JCI insight, 2024 - ncbi.nlm.nih.gov
Patients with Fabry disease suffer from chronic debilitating pain and peripheral sensory
neuropathy with minimal treatment options, but the cellular drivers of this pain are unknown …

[HTML][HTML] Sensory-specific peripheral nerve pathology in a rat model of Fabry disease

TB Waltz, AJ Burand Jr, KE Sadler, CL Stucky - Neurobiology of Pain, 2021 - Elsevier
Fabry disease (FD) causes life-long pain, the mechanisms of which are unclear. Patients
with FD have chronic pain that mirrors symptoms of other painful peripheral neuropathies …

The complex association of daily opioid dose with visits for pain in sickle cell disease: Tolerance or treatment-refractory pain?

EJ Prince, LH Pecker, S Lanzkron, CP Carroll - Pain Medicine, 2023 - academic.oup.com
Introduction Opioids are used for acute and chronic pain in patients with sickle cell disease.
How outpatient opioid regimens relate to acute care visits is of interest given the risks of high …

Prevalence of neuropathic pain in adolescents with sickle cell disease: a single‐center experience

M Cregan, L Puri, G Kang… - Pediatric blood & …, 2022 - Wiley Online Library
Background Neuropathic pain (NP) has been previously explored in adolescents with sickle
cell disease (SCD). This study aims to describe the prevalence of NP in adolescents with …